Terminated NA INTERVENTIONAL 2-arm NCT04321434

Hyperoxia and Microvascular Dysfunction

Cardiac and Subcutaneous Microvascular Dysfunction in Patients With Ischemic Heart Disease: Effects of an Acute Oxidative Stress

Sponsor: Université Libre de Bruxelles

Conditions Coronary Microvascular Disease Ischemic Heart Disease Microvascular Disease

Interventions Hyperoxia Normoxia laser Doppler

Updated 4 times since 2020 Last updated: Mar 24, 2020 Started: Dec 1, 2016 Primary completion: Apr 1, 2018 Completion: Oct 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Futility

This NA trial investigates Coronary Microvascular Disease and Ischemic Heart Disease and is currently terminated or withdrawn. Université Libre de Bruxelles leads this study, which shows 4 recorded versions since 2016 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Apr 2020 — Jan 2021 [monthly]

Terminated NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Université Libre de Bruxelles

Data source: Université Libre de Bruxelles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium